HomeRMTI • NASDAQ
add
Rockwell Medical Inc
Previous close
$1.02
Day range
$0.96 - $1.01
Year range
$0.96 - $5.15
Market cap
34.06M USD
Avg Volume
281.42K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 24.66M | 11.64% |
Operating expense | 4.15M | 21.45% |
Net income | -756.00K | 50.00% |
Net profit margin | -3.06 | 55.26% |
Earnings per share | — | — |
EBITDA | 24.00K | 700.00% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 21.60M | 97.55% |
Total assets | 59.21M | 13.48% |
Total liabilities | 26.62M | -13.79% |
Total equity | 32.59M | — |
Shares outstanding | 34.06M | — |
Price to book | 1.06 | — |
Return on assets | -2.23% | — |
Return on capital | -2.90% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -756.00K | 50.00% |
Cash from operations | 865.00K | 2,111.63% |
Cash from investing | -332.00K | -116.53% |
Cash from financing | 2.79M | 476.28% |
Net change in cash | 3.32M | 171.57% |
Free cash flow | 721.00K | 92.97% |
About
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease and chronic kidney disease.
The company's primary customers are dialysis providers. Wikipedia
Founded
1996
Headquarters
Website
Employees
244
